Daniel R. Schimmel, MD, explains how balloon pulmonary angioplasty (BPA) uses balloons and specialized catheters to open narrowed vessels in the lungs to improve circulation and reduce symptoms…
Nick Norwitz interviews Aseem Malhotra, MD, a consultant cardiologist, on controversial new findings challenging LDL cholesterol’s role as an independent risk factor for heart disease. They discuss data…
NEW YORK (Reuters Health) – Compared to bare metal stent implantation, patients with acute myocardial infarction and failed thrombolysis who undergo percutaneous coronary intervention (PCI), do no better…
NEW YORK (Reuters Health) – Standard echocardiography will confirm or exclude a patent foramen ovale (PFO) in most children, without the need for transesophageal echocardiography (TEE), clinicians from…
NEW YORK (Reuters Health) – Drug-eluting stents (DES) seem to be safer and more effective than bare-metal stents in saphenous vein grafts (SVG), according to a systematic review…
NEW YORK (Reuters Health) – In a pilot study of patients undergoing on-pump coronary artery bypass grafting (CABG), adding clopidogrel to aspirin did not reduce overall graft occlusion,…
NEW YORK (Reuters Health) – Acute hyperglycemia, even without diabetes, raises the risk of contrast-induced nephropathy and death in patients with ST-elevation myocardial infarction (STEMI) undergoing percutaneous coronary…
NEW YORK (Reuters Health) – The combination of aspirin and clopidogrel is no better than aspirin alone for preventing saphenous vein graft (SVG) intimal hyperplasia after coronary artery…
NEW YORK (Reuters Health) – In a prospective study, the beta-1 selective blocker bisoprolol proved more effective than the non-selective beta-blocker carvedilol in preventing atrial fibrillation after coronary…
NEW YORK (Reuters Health) – Smoking does not affect outcomes after early clopidogrel use in patients with acute coronary syndrome (ACS), according to findings published in the November…
NEW YORK (Reuters Health) – Hydroxychloroquine may reduce the heightened risk of cardiovascular disease in patients with rheumatoid arthritis. Use of hydroxychloroquine to treat rheumatoid arthritis is associated…
NEW YORK (Reuters Health) – The management of heart failure guided by an individualized target level of N-terminal pro-B-type natriuretic peptide (NT-proBNP) doesn’t lead to clinically significant improvements…
